🇺🇸 FDA

Company profile · Sponsor

Bayer

Bayer Schering Pharma AG

EC5EF19 · EMA pharma EU
Pipeline
2
Drugs
0
Patents
0

Quick answer

Bayer (EC5EF19) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EC5EF19
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (2)

Search pipeline →

  1. First-in-human study of 225Ac-PSMA-Trillium (BAY 3563254) in participants with advanced metastatic castration-resistant prostate cancer (mCRPC)

    Bayer

    Advanced metastatic castration-resistant prostate cancer with prostate specific membrane antigen (PSMA) expression

    phase 1 other active

    1 trial

  2. BEYONTTRA 356 mg film-coated tablets

    Bayer

    Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

    approved small molecule active

    1 trial

Frequently asked questions

What is Bayer?

Bayer (EC5EF19) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Bayer sponsor?

We track 2 ClinicalTrials.gov-linked programs for Bayer, including First-in-human study of 225Ac-PSMA-Trillium (BAY 3563254) in participants with advanced metastatic castration-resistant prostate cancer (mCRPC) and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Bayer company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.